Brief Reports
Copyright ©The Author(s) 2001.
World J Gastroenterol. Jun 15, 2001; 7(3): 431-434
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.431
Table 1 Positive rates of CEA, CA19-9 and CA72-4 in accordance with pathologic findings
Pathological factorsNo. of casesCEA positive (%)P valueCA19-9 positive (%)P valueCA72-4 positive (%)P value
Histological type
Well, moderately7330.1> 0.0524.7> 0.0526.00.031
Poorly34290426.447.1
Tumor size (cm)
≤ 55731.6> 0.0522.8> 0.0528.1> 0.05
> 55028.028.038.0
Gross morphology
Polypoid, fungating4528.9> 0.0526.7> 0.0533.3> 0.05
Ulcerative4129.324.431.7
Diffusely infiltrative2133.323.833.3
Depth of invasion*
Within sm2213.60.0169.10.04813.60.012
dm, s5425.924.129.6
sp3148.438.751.6
No. of positive lymph nodes
06129.5> 0.0514.80.01121.30.008
1-31631.331.337.5
> 33030.043.353.3
Dukes stage
A812.50.0410.00.0190.00.003
B5320.818.924.5
C3339.430.339.4
D1353.853.869.2
Table 2 Recurrence rates in patients with positive and negative serum levels of CEA, CA19-9 and CA72-4 who underwent curative resection
Tumor markersNo. of casesRecurrence rate (%)P value
CEApositive2445.80.102
negative6227.4
CA19-9positive1952.60.034
negative6726.9
CA72-4positive2454.20.008
negative6224.2